ClinVar Miner

Submissions for variant NM_000492.3(CFTR):c.742A>G (p.Arg248Gly) (rs1554380515)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000671274 SCV000796233 uncertain significance Cystic fibrosis 2017-12-07 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV001002407 SCV001160338 likely pathogenic not specified 2019-02-19 criteria provided, single submitter clinical testing The CFTR c.742A>G; p.Arg248Gly variant is reported in the literature in three siblings affected with pancreatitis or congenital absence of the vas deferens (Villalona 2017). In all three affected siblings, this variant was observed in trans to a second pathogenic variant (Villalona 2017). The p.Arg248Gly variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The arginine at codon 248 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Another variant at the same codon (p.Arg248Thr) has been reported in individuals with CFTR-related disorders in trans to a pathogenic variant (Polizzi 2011, SickKids CFTR Mutation Database). Additionally, the c.742A>G; p.Arg248Gly occurs in the penultimate nucleotide of an exon, and computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical donor splice site. Although this variant is unlikely to be causative for classic cystic fibrosis, based on available information, we consider this variant to be likely pathogenic for other CFTR-related disorders. References: SickKids CFTR Mutation Database: Polizzi A et al. Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele. Genet Mol Biol. 2011 Jul;34(3):416-20. Villalona S et al. R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series. J Med Case Rep. 2017 Feb 15;11(1):42.
Mayo Clinic Laboratories, Mayo Clinic RCV001509315 SCV001715949 uncertain significance not provided 2021-03-10 criteria provided, single submitter clinical testing
Nilou-Genome Lab RCV000671274 SCV001822019 uncertain significance Cystic fibrosis 2021-07-22 criteria provided, single submitter clinical testing
Natera, Inc. RCV000671274 SCV001454030 likely pathogenic Cystic fibrosis 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.